Concepedia

Masato Horikawa

MH

14

Publications

686

Citations

14

H-Index

1987

Active since

Affiliations

The University of Tokyo(Current)

Nissan Chemical Corporation (Japan)

Nara Medical University

Japan Science and Technology Agency

Menlo School

Masato Horikawa is an author at The University of Tokyo specializing in medicine, regenerative medicine, and tissue engineering.

Top concepts

Publications per year

1987–2021

14

Publications

14

The Potential for an Interaction between MRP2 (ABCC2) and Various Therapeutic Agents: Probenecid as a Candidate Inhibitor of the Biliary Excretion of Irinotecan Metabolites

Masato Horikawa, Yukio Kato, Charles A. Tyson et al. · Drug Metabolism and Pharmacokinetics · 2002 · 102 citations · Full text

A Mycoplasma genitalium protein resembling the Mycoplasma pneumoniae attachment protein

Ping Hu, U Schaper, Albert M. Collier et al. · Infection and Immunity · 1987 · 92 citations · Full text

, , +13

Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

Kiyomi Ito, Kōji Chiba, Masato Horikawa et al. · AAPS PharmSci · 2002 · 86 citations · Full text

The Quantitative Prediction of In Vivo Enzyme-Induction Caused by Drug Exposure from In Vitro Information on Human Hepatocytes

Motohiro Kato, Kōji Chiba, Masato Horikawa et al. · Drug Metabolism and Pharmacokinetics · 2005 · 80 citations

Reduced Gastrointestinal Toxicity Following Inhibition of the Biliary Excretion of Irinotecan and Its Metabolites by Probenecid in Rats

Masato Horikawa, Yukio Kato, Yuichi Sugiyama · Pharmaceutical Research · 2002 · 70 citations

Rows per page

1–5 of 14